Great, Mr Basile bought some at $11.99/share.
Mr Joe Basile, FIPA, FFA
Non-Executive Director
Joe joined the Neuren Board in 2023. He has held a number of executive roles in the pharmaceutical industry for over 30 years, most recently as Group CFO at iNova Pharmaceuticals based in Singapore and prior to that with Novartis in senior Finance leadership and Commercial Sales leadership roles in Australia and Asia.
TPG Capital to buy iNova for $2b-plus; PEP to co-invest
Anthony Macdonald, Sarah Thompson and Kanika Sood
Updated Jul 26, 2022 – 2.21pm,first published at 11.07am
Private equity firm TPG Capital’s Aussie hot-streak is gaining steam, with the group set to acquire medicine and healthcare products company iNova Pharmaceuticals.
Ann: Change of Director's Interest Notice - J Basile, page-2
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.72 |
Change
-0.240(1.15%) |
Mkt cap ! $2.645B | |||
| Open | High | Low | Value | Volume |
| $21.00 | $21.21 | $20.31 | $15.80M | 766.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | $20.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.72 | 3108 | 1 |
View Market Depth
| Last trade - 16.10pm 30/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$20.75 |
Change
-0.240 ( 1.47 %) |
||||
| Open | High | Low | Volume | ||
| $20.97 | $21.15 | $20.32 | 199599 | ||
| Last updated 15.59pm 30/05/2024 ? | |||||
| NEU (ASX) Chart |